88,500.00
+2700(+3.15%)
Currency In KRW
Address
16 Daewangpangyo-Ro 712 Beon-Gil
Seongnam, 13488
Korea, Republic of
Phone
82 31 8018 9800
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
102
First IPO Date
December 19, 2018
| Name | Title | Pay | Year Born |
| Dr. Sang Hoon Lee Ph.D. | Founder, President & Chief Executive Officer | 0 | N/A |
| Mr. Jung Dae Kim M.B.A. | Executive Vice President & Chief Operating Officer | 0 | N/A |
| Mr. Jaecheon Lee M.B.A., MBA | Executive Vice President, MD & Chief Financial Officer | 0 | N/A |
| Dr. You Weon-Kyoo PH.D. | Executive Vice President, Chief Scientific Officer & Head of R&D | 0 | N/A |
| Dr. Jong Hwa Won Ph.D. | Executive Vice President, Chief Translational Research Officer & Head of Early Development | 0 | N/A |
| Dr. Jaeho Jung Ph.D. | Executive Vice President & Chief of Discovery | 0 | N/A |
| Dr. Eunkyung Kim M.D., Ph.D. | Head of Medical & Clinical Development | 0 | N/A |
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. The company is headquartered in Seongnam, South Korea.
